<DOC>
	<DOCNO>NCT02626663</DOCNO>
	<brief_summary>The investigator propose characterize MPs aHUS TTP onset throughout treatment . The investigator believe number , size , cell origin MPs differ two disease . The hypothesis endothelial derive MPs high number comprise large portion MP population aHUS platelet MPs comprise large number great proportion MPs TTP . The investigator believe MP identity number use reliably differentiate aHUS TTP disease onset .</brief_summary>
	<brief_title>The Role Microparticles Biomarker</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Hemolysis</mesh_term>
	<mesh_term>Azotemia</mesh_term>
	<mesh_term>Hemolytic-Uremic Syndrome</mesh_term>
	<mesh_term>Atypical Hemolytic Uremic Syndrome</mesh_term>
	<mesh_term>Purpura , Thrombotic Thrombocytopenic</mesh_term>
	<mesh_term>Anemia , Hemolytic</mesh_term>
	<criteria>Patients MAHA , TTP , and/or aHUS Prisoners</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>